Navigation Links
Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
Date:6/4/2009

we have a therapeutic area focus, an open innovation approach, an outcomes-based drug development strategy, broad-based expertise and global reach, and truly outstanding people."

The company is continuing to advance its pipeline of new compounds, while also exploring line extensions for existing drugs, which have the potential to become what the company calls a "pipeline in a product." Among some of the early stage compounds being discussed today are the company's first compound for treating type 2 diabetes, the SGLT2 inhibitor, and CNTO-888, which has the potential for indications in both immunology and oncology. Stoffels and other executives will discuss the company's expectations for new filings and early-stage compounds across each of the five therapeutic areas throughout the day.

"Our pipeline is robust and consists of compounds that are differentiated and meet unmet needs in global and large regional markets. And our commercial teams around the world are working to deliver enhanced clinical and economic value," says McCoy. "All of this together gives me great confidence in our ability to make a real difference in patients' lives."

Full copies of the presentations as well as a replay and podcast will be available approximately two hours after the live webcast concludes at www.investor.jnj.com.

About Johnson & Johnson

Caring for the world, one person at a time ... inspires and unites the people of Johnson & Johnson. We embrace research and science -- bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 119,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

(This press release contains "forwa
'/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
2. Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
3. Champions Shawn Johnson & Phil Jackson Wear Energy Muse Jewelry
4. Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference
5. Johnson & Johnson to Host Analyst Conference Call To Review Six-Month Trial Results From NEVO RES I
6. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
7. Johnson & Johnson to Participate in Bank of America and Merrill Lynch 2009 Health Care Conference
8. Weill Cornell and Cornells Johnson School present first annual business and medicine symposium
9. Johnson & Johnson to Webcast Annual Meeting of Shareholders
10. Johnson & Johnson Reports 2009 First-Quarter Results:
11. Trust for Americas Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... August 01, 2015 , ... Western University of Health ... that comprises a growing percentage of U.S. physicians, and reflects the diversity of ... part of the message delivered by John W. Becher, DO, president of the ...
(Date:8/1/2015)... ... August 01, 2015 , ... Tina Wilcoxson, owner of Freeport ... was given that honor by the National Retail Federation, the largest retail trade association ... one of three Maine business owners to be named as such. According to the ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, ... to download on the Apple AppStore. , The app is designed to track ... acting as a tool to view personal health and use this information for positive ...
(Date:7/31/2015)... Rosa, CA (PRWEB) , ... July 31, 2015 ... ... posted by High Times magazine. What are the STASH awards? The Significant ... advances made by the cannabis-cultivation community as well as tried-and-true products that have ...
(Date:7/31/2015)... (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 will emanate ... Football League’s biggest day each year is the Super Bowl. In the two weeks that ... place from the host venue. The 2016 Super Bowl game will mark the 50th time ...
Breaking Medicine News(10 mins):Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Local Retail Advocate Wins National Recognition 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
... better than MR arthrography for diagnosing glenoid rim osseous lesions, ... after shoulder surgery, according to a new study. ... Marseille, France, included 40 patients scheduled for shoulder surgery. ... MR arthrography exam (the current standard exam). "Our study found ...
... , TUESDAY, May 3 (HealthDay News) -- ... Federal Trade Commission are cracking down on manufacturers of ... sexually transmitted diseases. The agencies jointly sent letters ... An Outbreak, warning that their products are unproven and ...
... scientists have proposed food restriction as a way to extend ... lengthened the life spans of mice, rats and many other ... that food restriction does not work in all cases. ... Health Science Center San Antonio,s Barshop Institute for Longevity and ...
... , TUESDAY, May 3 (HealthDay News) -- A new ... lower body that are scanned when looking for blood clots ... significantly reduce the exposure to radiation. The imaging test, ... blood clot in the veins. Such clots usually form in ...
... Rice University senior engineering students are using the sun to ... a long-standing health issue for developing countries. The ... French inventor Jean Boubour to capture the energy of the ... kind -- is hard to get. In attaching an insulated ...
... News) -- Although studies have shown that indoor tanning raises ... staggering 75 percent, a new survey reveals that young women ... In the past year, 32 percent of the 3,800 young ... they had visited a tanning salon. In fact, 25 percent ...
Cached Medicine News:Health News:U.S. Officials Take Aim at Questionable STD Products 2Health News:Mouse study turns fat-loss/longevity link on its head 2Health News:Expert Suggests Skipping Pelvis When Scanning for Clots 2Health News:Rice U. parlays sun's saving grace into autoclave 2Health News:Survey Shows Dangers of Tanning Not Hitting Home 2
(Date:7/31/2015)... -- Semler Scientific, Inc. (Nasdaq: SMLR ), a company ... and physician groups, today reported financial results for the ... "In the second quarter of 2015, Semler reported continued ... quarter over quarter revenue growth of 8%, and quarter ... units of 18%," said Doug Murphy-Chutorian, M.D., chief executive ...
(Date:7/30/2015)... Calif. , July 30, 2015 Edwards Lifesciences ... science of heart valves and hemodynamic monitoring, today announced that ... Board of Directors. "Bob is an ardent champion ... a true privilege to have him on Edwards, board as ... Mussallem , Edwards, chairman and CEO.  "Bob has provided a ...
(Date:7/30/2015)... , July 30, 2015  Tandem Diabetes ... device company and manufacturer of the t:slim® and ... entered into non-exclusive Development Agreements with Dexcom, Inc. ... insulin pumps with the Dexcom G5 and G6 ... Tandem,s next generation pump platform with Dexcom,s future ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... Entry into Oncology Market; Rosetta to Receive Milestones ... DIEGO, PHILADELPHIA and REHOVOT, Israel, April 13 ... company, and Rosetta Genomics Ltd. (Nasdaq: ... announced the execution of a license and collaboration ...
... - Additional Presentations Underscore Potency, Binding Capabilities for ... 9 InNexus Biotechnology Inc. (Toronto Stock Exchange: ... commercializing the next generation of monoclonal antibodies based ... today that the company will be presenting new ...
Cached Medicine Technology:Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 2Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 3Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 4Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 5Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 6AACR Data Highlights InNexus Preclinical Antibody Candidate 2
Donor Screen & Confirmation Kit...
... antibody gives positive staining of prostatic ... hyperplasia. In cases of prostatic cancer, ... give definite but weak staining or ... cells; this pattern of staining permits ...
... comprehensive line of pregnancy tests including rapid ... convenient one-step stick and cassette formats. The ... Easy HCG is a 25 mIU urine ... HCG II provides 25mIU sensitivity for ...
For the quantitative determination of Glycohemoglobin (HbA1) in blood by,cation exchange resin. The test is to be used to monitor long-term glucose,control in diabetes mellitus....
Medicine Products: